Fremanezumab
Fremanezumab is a pharmaceutical drug with 24 clinical trials. Currently 4 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
4
Mid Stage
14
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
58.8%
10 of 17 finished
41.2%
7 ended early
4
trials recruiting
24
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45
A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age
A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine
Migraine Medication Effects on Urinary Symptoms
Clinical Trials (24)
Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45
A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age
A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine
Migraine Medication Effects on Urinary Symptoms
Fremanezumab Compassionate Use Program for Pediatric Patients
A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity
CGRP Inhibition, Autonomic Function, and Migraine
Fremanezumab for the Prevention of Menstrually-related Migraine Attacks
Real World Effectiveness of Eptinezumab in Participants With Migraine
A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder
A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia
A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)
Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study
Safety and Efficacy of Fremanezumab for Migraine in Adult CADASIL
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)
A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain Syndrome
Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 24